BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7155700)

  • 1. [Correlation between spirometric indices and ambulatorial clinical checking of patients with cystic fibrosis].
    Rigillo N; Manca A; Mallardi A; Corrado R
    Pediatria (Napoli); 1982 Sep; 90(3):259-67. PubMed ID: 7155700
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between impulse oscillometry and spirometric indices in cystic fibrosis children.
    Moreau L; Crenesse D; Berthier F; Albertini M
    Acta Paediatr; 2009 Jun; 98(6):1019-23. PubMed ID: 19469720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF.
    Owens CM; Aurora P; Stanojevic S; Bush A; Wade A; Oliver C; Calder A; Price J; Carr SB; Shankar A; Stocks J;
    Thorax; 2011 Jun; 66(6):481-8. PubMed ID: 21422040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function study in normal Thai children; comparison of spirometric measurements using simple vitalor respirometer and standard spirometer.
    Suwanjutha S; Watthana-Kasetr S; Inthraphuvasak V; Vongvivat K; Kittikool J
    J Med Assoc Thai; 1984 Sep; 67(9):504-16. PubMed ID: 6520575
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing correlations between spirometry and Shwachman-Kulczycki score in children and adolescents.
    Assis I; Camargos PA; Reis FJ; Sulmonett N; Carneiro AP
    Pediatr Pulmonol; 2003 Oct; 36(4):305-9. PubMed ID: 12950043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Cavitron Spirometric Computer for accuracy in clinical screening spirometry.
    Cissik JH; Cramer TJ; Shelman LL
    Aviat Space Environ Med; 1981 Feb; 52(2):125-9. PubMed ID: 7213297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circadian variations of airway resistance in children. Comparison of FEV and MMEFR].
    Castello D; Candussion G
    Bronchopneumologie; 1978; 28(3):233-40. PubMed ID: 756790
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Keller BM; Aebischer CC; Kraemer R; Schöni MH
    J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary function in symptom-free asthmatics.
    Yaacob I; Mohammad M
    Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the partial pressure of arterial oxygen and airflow limitation in children with cystic fibrosis.
    Desmond KJ; Coates AL; Beaudry PH
    Can Med Assoc J; 1984 Aug; 131(4):325-6. PubMed ID: 6430539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
    Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
    J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales.
    McKay KO; Waters DL; Gaskin KJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S47-50. PubMed ID: 16202782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measuring maximal expiratory flow brought to 25-75% of vital capacity, as an epidemiological method in the early detection of obstruction of peripheral airways].
    Amaral-Marques R; Cochito ML; Cruz M; Villar MW; Villar TG
    Bronchopneumologie; 1980; 30(6):499-507. PubMed ID: 7326593
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary function testing in the pediatric outpatient.
    Ganeshananthan M; Fink RJ
    Pediatr Ann; 1986 Apr; 15(4):323-4, 328-9. PubMed ID: 3714332
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lung function in mucoviscidosis: which marker is the most telling?].
    Reinhardt D
    MMW Fortschr Med; 2014 Apr; 156(6):28. PubMed ID: 24919288
    [No Abstract]   [Full Text] [Related]  

  • 16. Determining the time to maximal bronchodilator response in asthmatic children.
    Stavreska V; Verheggen M; Oostryck J; Stick SM; Hall GL
    J Asthma; 2009 Feb; 46(1):25-9. PubMed ID: 19191133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and interpretation of forced expiration.
    Menkes H; Cohen B; Permutt S; Beatty T; Shelhamer J
    Ann Biomed Eng; 1981; 9(5-6):501-11. PubMed ID: 6753665
    [No Abstract]   [Full Text] [Related]  

  • 18. Spirometry and flow-volume curve in patients with obstructive sleep apnea.
    Ashraf M; Shaffi SA; BaHammam AS
    Saudi Med J; 2008 Feb; 29(2):198-202. PubMed ID: 18246226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced lung function in cystic fibrosis: a primary or secondary phenotype?
    Davis SD; Ratjen F
    Am J Respir Crit Care Med; 2008 Jul; 178(1):2-3. PubMed ID: 18565959
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve.
    Motoyama EK; Gibson LE; Zigas CJ
    Pediatrics; 1972 Aug; 50(2):299-306. PubMed ID: 5045357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.